Curtiss-Wright Corporation filings document financial results, governance matters and capital actions for an operating company serving Aerospace & Defense, commercial nuclear power, process and industrial markets. Recent Form 8-K reports furnish quarterly and annual results releases, webcast presentations and outlook commentary tied to the company’s operating markets.
Proxy materials and annual-meeting reports cover director elections, independent auditor ratification and advisory executive-compensation votes. Other Form 8-K disclosures describe common-stock repurchase authorizations, Rule 10b5-1 trading plans, potential repurchase methods and related risk language under the Exchange Act.
Curtiss-Wright executive John C. Watts reported routine share transactions in company stock. On February 3, 2026, he acquired 1,354 shares of common stock through a performance share grant under the 2014 Long Term Incentive Plan, based on three-year total shareholder return versus a peer group.
On February 4, 2026, Watts sold 652 shares of common stock at an average price of $625.57 per share, in line with company share ownership guidelines that allow sales to cover individual income tax obligations from vesting. After these transactions, he directly owned 3,890 Curtiss-Wright common shares.
Curtiss-Wright senior vice president and treasurer Robert F. Freda reported an equity award vesting and a related share sale. On February 3, 2026, he acquired 784 shares of common stock through a performance share grant under the 2014 Long Term Incentive Plan, based on three-year total shareholder return versus a peer group, at a reference price of $674.32 per share.
On February 4, 2026, Freda sold 418 shares of common stock at an average price of $626.95, with individual trades ranging from $611.26 to $658.97. The sale was conducted under company share ownership guidelines to cover income tax obligations from the vesting. After these transactions, he directly held 5,187 shares of Curtiss-Wright common stock.
Curtiss-Wright Corporation Executive VP and COO Kevin Rayment reported stock transactions related to a long-term incentive award. On February 3, 2026, he acquired 6,618 shares of common stock through a performance share grant under the 2014 Long Term Incentive Plan, based on the company’s three-year total shareholder return versus its peer group, at a reference price of $674.32 per share.
On February 4, 2026, he sold 2,634 shares of common stock, in transactions averaging $626.33 per share, with actual prices ranging from $608.82 to $660.05. The filing states these sales were made in line with the company’s share ownership guidelines, allowing the executive to sell part of the vested shares to cover individual income tax obligations from the award vesting. After these transactions, he directly owned 29,896 shares of Curtiss-Wright common stock.
Curtiss-Wright Corporation’s Executive VP and CFO K. Christopher Farkas reported a performance-based stock grant and a related share sale. On February 3, 2026, he acquired 5,770 shares of common stock through a performance share grant under the company’s 2014 Long Term Incentive Plan, valued using the $674.32 NYSE closing price on the vesting date.
On February 4, 2026, he sold 2,665 shares at an average price of $626.33, with prices ranging from $609.29 to $660.49, to cover individual income tax obligations tied to vesting. After these transactions, he directly owned 7,358 shares of Curtiss-Wright common stock.
Curtiss-Wright Corporation’s Chair and CEO Lynn M. Bamford reported equity award vesting and a related share sale. On February 3, 2026, she acquired 20,268 shares of common stock through a performance share grant under the company’s 2014 Long Term Incentive Plan, based on three-year total shareholder return versus peers, using $674.32 as the NYSE closing price on the vesting date.
On February 4, 2026, she sold 9,327 shares of common stock at an average price of $626.45 per share, with the sale described as complying with company share ownership guidelines that allow sales to cover individual income tax obligations from vesting. After these transactions, she directly held 46,192 shares of Curtiss-Wright common stock.
Curtiss-Wright Senior VP & Corp Controller Gary A. Ogilby reported equity award vesting and related share sales. On February 3, 2026, he acquired 1,060 shares of common stock through a performance share grant under the 2014 Long Term Incentive Plan, based on three-year total shareholder return versus a peer group.
Also on February 3, 2026, these shares vested at a reference price of $674.32 per share, the New York Stock Exchange closing price that day. On February 4, 2026, he sold 435 shares at an average price of $626.56, and on February 5, 2026, he sold 625 shares at an average price of $624.32. The filing states that a portion of vested shares was sold in line with company share ownership guidelines to cover income tax obligations, and that the February 5 sale was made under a Rule 10b5-1 trading plan adopted on September 11, 2025.
Following these transactions, Ogilby directly beneficially owned 2,571 shares of Curtiss-Wright common stock.
An insider associated with CW has filed a Rule 144 notice to sell 625 shares of common stock through UBS Financial Services Inc. on or about 02/05/2026 on the NYSE, with an aggregate market value of $385,359.38.
The 625 shares were acquired from the issuer on 02/03/2026 via a performance share unit (PSU) transaction. As context, the filing lists 36,874,638 common shares outstanding and notes a recent sale of 435 shares on 02/04/2026 for gross proceeds of $272,427.46.
A holder of 435 shares of common stock has filed a notice of proposed sale under Rule 144. The shares were acquired through a performance stock vest from the issuer on 02/03/2026 and are to be sold through UBS Financial Services Inc.
The filing lists an aggregate market value of 272,427.46 for these shares, with an approximate sale date of 02/03/2026 on the NYSE. The filer represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
John Watts filed a Rule 144 notice to sell 652 common shares of CW. The planned sale, through UBS Financial Services Inc. on the NYSE, has an aggregate market value of $407,748.55, with 36,874,638 shares of this class outstanding.
The 652 shares were acquired on 02/03/2026 via a performance stock vest from the issuer. Over the prior three months, John Watts sold additional CW common shares in several transactions totaling 688 shares, with reported gross proceeds ranging from $61,935 to $172,800 per transaction.
A holder of common shares of CW has filed a Rule 144 notice to sell 2,634 shares through UBS Financial Services on the NYSE, with an aggregate market value of 1,649,611.39. The filing notes total shares outstanding of 36,874,638 and an approximate sale date of 02/04/2026. The shares were acquired on 02/03/2026 via a performance stock vest from the issuer for the same 2,634-share amount.